● Market/Competitive Assessment with Indication Prioritization: assessments and strategic options to drive business value and improve patient standard of care. Experience across a range of indications and therapies in various stages of development and commercialization
Project/Program Management for cross functional teams
● Global Medical Affairs project lead for mRNA vaccine company: strategic plan and global events
● Pre-IND Candidate Development: very early-stage novel allergy focused company
● Antigen-directed Immunotherapy early stage: go-to consultant since 2017, including: landscape, competitive and BD analysis and project leader for pre-IND/IND preparations
● Reverse Merger: Key member of a team that planned, evaluated, and sourced candidates for a reverse merger of a listed stem cell business into a new clinical-stage biopharmaceutical company
● Merger: global pharmaceutical company acquisition of a $2B oncology business in 2021. Worked with a 30+ team.

UCSF Lean Launch Program San Francisco, CA
● Created and validated product market fit focused on improving quality of life for cancer survivors. This included 100+ interviews of potential customers and stakeholders.
● Crafted the business model, financial operating plan, and company introduction video and pitch for potential investors.

● Portfolio Level Decision Making: Strengthened the late-stage Portfolio Committee charter, revised early and late-stage team training and submission documents, and aligned the global project manager website resources to support stakeholders and teams
● Senior executive crowd sourcing

Consultant working with the CEO to crafting a rebranding program.

● Market and Business Planning: Headed five-year growth strategy planning for $500M business resulting in top market leadership in a very competitive market.
● Drove the R&D business case analysis (7 key product launches in 3 years).
● Facilitated division and corporate leadership off sites and strategy discussions.
● Served as the trusted counsel and chief of staff to Business President

Managed engagements addressing critical strategic and operational issues of Fortune 500 clients. Examples:
● Post-merger integration program: with the CFO, developed and managed the financial center "up and running" plan, created the new financial operations corporate center and identified $15M in synergy opportunities.
● Merger of two blood lab service providers: formulated the merger agenda for operations, footprint, and sales (FTC postponed)
● Pharma global strategic alliances: Led the analysis for a $1+ billion global capital expenditure programs for a major global pharmaceutical company.
● Multiple complex business challenges: redesigned human resource strategy for a mortgage consumer bank, designed a pre-implementation for next generation lean manufacturing strategy for major airline manufacturer, analyzed European strategic sourcing for a global telecom, analyzed global market entry feasibility for a Swiss global manufacturing company, semiconductor margin improvements.